RayBio Label-Based (L-Series) Human Antibody Array 507 (L-507) or 493 (L-493) Patent Pending Technology User Manual (Revised September 9, 2014) For the simultaneous detection of the relative expression of 507 (L-507) or 493 (L-493) human proteins in serum, plasma, cell culture supernatants, cell/tissue lysates or other body fluids.
L-Series Human Antibody Array L-507 Cat# AAH-BLG-1-2 (2 Sample Kit) Cat# AAH-BLG-1-4 (4 Sample Kit) L-Series Human Antibody Array L-493 Cat# AAH-BLG-2-2 (2 Sample Kit) Cat# AAH-BLG-2-4 (4 Sample Kit)
Please read manual carefully before starting experiment
Your Provider of Excellent Protein Array Systems and Services Tel: (Toll Free) 1-888-494-8555 or +1-770-729-2992; Fax: +1-770-206-2393; Website: www.raybiotech.com Email:
[email protected]
TABLE OF CONTENTS I. II.
Introduction and How It Works…………………………………………………………………………………2 Materials Provided…………………………………………………………………………………………………………………… 3 A. Storage Recommendations…………………………………………………………………………………… 3 B. Additional Materials Required……………………………………………………………………..…… 3 III. Overview and General Considerations……………………………………………….…………… 4 A. Preparation and Storage of Samples………………………………………………………… 4 B. Handling the Glass Slides…………………………………………………………………………………….…… 6 C. Layout of Human L-507 or L-493 Slide…………………………………………..……… 7 D. Incubation and Washes……………………………………………………………………………………………… 7 IV. Protocol………………………………………………………………………………………………………………………………………..………… 8 A. Dialysis of Sample……………………………………………………………………………………………………………… 8 B. Biotin Labeling of Sample…………………………………………………………………………………………9 C. Drying of the Glass Slide…………………………………………………………………………………………… 11 D. Blocking and Incubations……………………………………………………………………………….…………11 E. Fluorescence Detection…………………………………………………………………………………..………… 14 V. Antibody Array Maps and Target Lists…………………………………………………..………… 15 A. RayBio Human Antibody Array L-507 Map………………………………………… 15 B. RayBio Human Antibody Array L-507 Target List…………………….… 16 C. RayBio Human Antibody Array L-493 Map………………………………………… 18 D. RayBio Human Antibody Array L-493 Target List……………….……… 19 VI. Interpretation of Results…………………………………………………………………………………………………… 21 A. Explanation of Controls Spots…………………………………………………………………….……… 21 B. Typical Results……………………………………………………………………………………………………………….……… 21 C. Background Subtraction……………………………………………………………………………………….……23 D. Normalization of Array Data…………………………………………………………………………………23 E. Threshold of Significant Difference…………………………………………………………..… 24 VII. Troubleshooting Guide………………………………………………………………………………………………..……… 25 VIII. Selected References……………………………………………………………………………………………………..………… 26 RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
1
I. Introduction Recent technological advances by RayBiotech have enabled the largest commercially available antibody array to date. With the L-Series Antibody Array 507 or L-493, researchers can now obtain a broad, panoramic view of cytokine expression. The expression levels of 507 or 493 human target proteins can be simultaneously detected, including cytokines, chemokines, adipokines, growth factors, angiogenic factors, proteases, soluble receptors, soluble adhesion molecules and other proteins in cell culture supernatants, serum and plasma. The first step in using the RayBio® L-Series Human Antibody Array 507 or L493 is to biotinylate the primary amine groups of the proteins in your sample (sera or plasma, cell culture supernatants, cell lysates or tissue lysates). The glass slide arrays are then blocked, just like a Western blot, and the biotin-labeled sample is added onto the glass slide, which is pre-printed with capture antibodies. The slide is incubated to allow binding of target proteins. Streptavidin-conjugated fluorescent dye (Cy3 equivalent) is then applied to the array. Finally, the glass slide is dried, and laser fluorescence scanning is used to visualize the signals.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
2
II. Materials Provided A. Storage Recommendations Upon receipt, the kit should be stored at -20°C until needed. Use within 6 months from the date of shipment is recommended. After initial use, remaining reagents should be stored at 4°C and may be stored for up to 3 months (Labeling Reagent, Item B, should be prepared fresh each time before use). Unused glass slides should be kept at -20 °C and repeated freeze-thaw cycles should be avoided (slides may be stored for 6 months). DESCRIPTION ITEM
NOTE: all components (except slides) are identical between the L-493 and L-507 kits
A B D
Dialysis Vials & Floating Dialysis Rack Labeling Reagent Stop Solution RayBio® L-Series Human Antibody Array L-507 or L-493 Glass Slides* Blocking Buffer 20X Wash Buffer I 20X Wash Buffer II Cy3-Conjugated Streptavidin** Adhesive Plastic Strips Labeling Buffer 2X Cell Lysis Buffer*** 30 ml Centrifuge Tube
E F G H I J K n/a M
AAH-BLG-1-2 (L-507) or AAH-BLG-2-2 (L-493)
AAH-BLG-1-4 (L-507) or AAH-BLG-2-4 (L-493)
4 vials 1 vial
8 vials 2 vials
1 vial (50 µl) 1 slide (L-507 or L2 slides (L-507 or L493) 493) 1 bottle (8 ml) 1 bottle (8 ml) 1 bottle (30 ml) 1 bottle (30 ml) 1 bottle (30 ml) 1 bottle (30 ml) 1 vial 2 vials 1 bottle (8 ml) 1 bottle (10 ml) 1 tube
*Each slide contains 2 identical subarrays **HiLyte PlusTM 555 ***Only needed if testing cell or tissue lysates
B. Additional Materials Required • • • • • • •
KCl, NaCl, KH2PO4, Na2HPO4 and ddH2O 1 ml tube, small plastic or glass containers Orbital shaker or oscillating rocker Beaker, stir plate and stir bar Pipettors, pipette tips and other common lab consumables Laser scanner for fluorescence detection (list available online) Aluminum foil
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
3
III. Overview and General Considerations A. Preparation and Storage of Samples 1) Preparation of Cell Culture Supernatants 1. Seed cells at a density of 1x106 cells in 100 mm tissue culture dishes.* 2. Culture cells in complete culture medium for ~24–48 hours.** 3. Replenish with serum-free or low-serum medium such as 0.2% FCS/FBS serum, and then incubate cells again for ~48 hours.**,† The membrane-based array is recommended if high serum medium such as 10% FCS/FBS is used, as high background can occur on glass slide arrays with high serum containing media samples. 4. To collect supernatants, centrifuge at 1,000 g for 10 min and store as ≤1 ml aliquots at -80°C until needed. 5. Measure the total wet weight of cultured cells in the pellet and/or culture dish. You may then normalize between arrays by dividing fluorescent signals by total cell mass (i.e., express results as the relative amount of protein expressed/mg total cell mass). Or you can normalize between arrays by determining cell lysate concentration using a total protein assay (BCA Protein Assay Kit, Pierce, Prod #: 23227). *The density of cells per dish used is dependent on the cell type. More or less cells may be required. **Optimal culture time may vary and will depend on the cell line, treatment conditions and other factors. †Bovine serum proteins produce detectable signals on the RayBio® LSeries Array in media containing serum concentrations as low as 0.2%. When testing serum-containing media, we strongly recommend testing an uncultured media blank for comparison with sample results. RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
4
2) Extracting Protein from Cells 1. Centrifuge Cells: a. Adherent Cells: i. Remove supernatant from cell culture and wash cells gently twice with cold 1X PBS taking care not to disturb cell layer. ii. Add enough cold 1X PBS to cover cell layer and use cell scraper to detach cells. Proceed to b. Cells in Suspension. b. Cells in Suspension: Pellet the cells by centrifuging using a microcentrifuge at 1500 rpm for 10 min. 2. Make sure to remove any remaining PBS before adding 1X Cell Lysis Buffer (2X Cell Lysis Buffer should be diluted 2 fold with ddH2O). Solubilize the cells at 2x107 cells/ml in 1X Cell Lysis Buffer. 3. Pipette up and down to resuspend cells and rock the lysates gently at 2–8 °C for 30 minutes. Transfer extracts to microfuge tubes and centrifuge at 13,000 rpm for 10 min at 2-8 °C. Note: If the lysates appear to be cloudy, transfer the lysates to a clean tube, centrifuge again at 13,000 rpm for 20 minutes at 2-8°C. If the lysates are still not clear, store them at -20°C for 20 minutes. Remove from the freezer and immediately centrifuge at 13,000 rpm for 20 minutes at 28°C. 4. Transfer lysates to a clean tube. Determining cell lysate concentrations using a total protein assay (BCA Protein Assay Kit, Pierce, Prod# 23227). Aliquot the lysates and store at -80°C. 3) Extracting Protein from Crude Tissue 1. Transfer approximate 100 mg crude tissue into a tube with 1 ml 1X Cell Lysis Buffer (2X Cell Lysis Buffer should be diluted 2 fold with ddH2O). RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
5
2. Homogenize the tissue according to homogenizer manufacturer instructions. 3. Transfer extracts to microcentrifuge tubes and centrifuge for 20 min at 13,000 rpm (4°C). Note: If the supernatant appears to be cloudy, transfer the supernatants to a clean tube, centrifuge again at 13,000 rpm for 20 minutes at 2-8°C. If the supernatant is still not clear, store the lysate at -20°C for 20 minutes. Remove from the freezer, immediately centrifuge at 13,000 rpm for 20 minutes at 2-8°C. 4. Transfer supernatant to a clean tube and store at -80°C. B. Handling the Glass Slides • The microarray slides are delicate. Please do not touch the array surface with pipette tips, forceps or your fingers. Hold the slides by the edges only. • Handle the slides with powder-free gloves and in a clean environment. • Do not remove the glass slide from the chamber assembly until step 20 on page 13, and take great care not to break the glass slide when doing so.
• Remove reagents/sample by gently applying suction with a pipette to corners of each chamber. Do not touch the printed area of the array, only the sides as seen in image below.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
6
C. Layout of Human L-507 and L-493 Glass Slide Two identical sub-arrays on one slide
D. Incubations and Washes • Cover incubation chamber with a Plastic Adhesive Strip (Item J) to prevent evaporation during incubation or wash steps, particularly those steps lasting 2 hours or longer. • During incubation and wash steps avoid foaming and remove all bubbles from the sub-array surface. • Perform all incubation and wash steps under gentle rotation or rocking motion (~0.5 to 1 cycle/sec). • Wash steps in Wash Buffer II and all incubation steps may be performed overnight at 4°C. • Avoid cross-contamination of samples to neighboring wells. To remove Wash Buffers and other reagents from chamber wells, you may invert the Glass Slide Assembly to decant, and aspirate the remaining liquid. • Unlike most Cy3 fluors, the HiLyte Plus™ 555 used in this kit is very stable at room temperature (RT) and resistant to photobleaching on the hybridized glass slides. However, please protect glass slides from directly strong light and temperatures above RT. RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
7
IV. Protocol Assay Diagram 1. Cell culture supernatants or cell/tissue lysates
2. Serum or plasma
Note: If using cell or tissue lysates, start at “Dialysis of sample” A. Dialysis of Sample Note: Samples must be dialyzed prior to biotin-labeling (Steps 5–7). 1. To prepare dialysis buffer (1X PBS, pH=8.0), dissolve 0.6 g KCl, 24 g NaCl, 0.6 g KH2PO4 and 3.45 g Na2HPO4 in 2500 ml ddH2O. Adjust pH=8.0 with 1M NaOH and adjust final volume to 3000 ml with ddH2O. 2. Add each sample into a separate Dialysis Tube (Item A). Loading volumes are as follows: 200 μl cell culture supernatant; 100 μl cell or tissue lysate (1~2 mg/ml total protein); 20 μl serum or plasma + 80 μl 1X PBS, pH=8 (5-fold dilution). Carefully place Dialysis Tubes into Floating Dialysis Rack.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
8
Note for cell culture supernatants: if using a 2-fold dilution of biotin-labeled sample in the array incubation step (page 11, step 11), you will need to load a total of 400 μl of original cell culture supernatant into 2 separate Dialysis Tubes (200 μl /tube). Note: If the samples appear to be cloudy, transfer the samples to a clean tube, centrifuge at 13,000 rpm for 20 minutes at 2-8°C. If the samples are still not clear, store them at -20°C for 20 minutes. Remove from the freezer, immediately centrifuge at 13,000 rpm for 20 minutes at 2-8°C. 3. Place Floating Dialysis Rack into ≥500 ml dialysis buffer in a large beaker. Place beaker on a stir plate and dialyze, for at least 3 hours at 4°C, stirring buffer gently. Then exchange the 1X PBS buffer and repeat dialysis for at least 3 hours at 4°C. Transfer dialyzed sample to a clean microfuge tube. Spin dialyzed samples for 5 min at 10,000 rpm to remove any particulates or precipitates, and then transfer the supernatants to a clean tube. Note: The sample volume may change during dialysis. Note: Dialysis procedure may proceed overnight. Note: Determine the total protein concentration for cell culture supernatants or cell/tissue lysate after dialysis procedure (Step 3). We recommended using a BCA total protein assay (eg, Pierce, Catalog # 23227). B. Biotin-labeling Sample Note: Amines (e.g., Tris, glycine) and azides quench the biotinylation reaction. Avoid contaminating samples with these chemicals prior to biotinylation. 4. Immediately before use, prepare 1X Labeling Reagent. Briefly spin down the Labeling Reagent tube (Item B). Add 100 µl 1X PBS into the tube, then pipette up and down or vortex slightly to dissolve the lyophilized reagent. 5. Add 1X Labeling Reagent to dialyzed samples. RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
9
a. For labeling cell culture supernatants: transfer 180 μl dialyzed sample into a new tube. Add 36 μl of 1X Labeling Reagent Solution per 1 mg total protein in dialyzed cell culture supernatant. Mix well. For example, if sample’s total protein concentration is 0.5 mg/ml you need to add 3.24 µl 1X Labeling Reagent to the tube of 180 μl dialyzed sample. Note: You need to biotin-label 360 μl of dialyzed sample if dilution of the biotin-labeled samples is 2 fold in step 11 on page 11. b. For labeling serum or plasma: Add 22 μl of 1X Labeling Reagent Solution into a new tube containing 35 μl dialyzed serum or plasma sample and 155 μl Labeling Buffer (Item K). c. For labeling cell or tissue lysates: transfer 30 µg (15 μl of 2 mg/ml) cell or tissue lysates into a tube and add labeling buffer (Item K) for a total volume of 260 μl. Then add 3.3 μl of 1X Labeling Reagent Solution. Note: To normalize serum/plasma or cell/tissue lysate concentrations during biotinylation, measure sample volume before and after dialysis. Then adjust the volumes of dialyzed serum/plasma or cell/tissue lysates and Labeling Buffer to compensate. For example, if the sample volume doubles after dialysis, then use twice as much serum/plasma in the labeling reaction (70 μl) and reduce the Labeling Buffer to 120 μl. 6. Incubate the reaction solution at RT with gentle rocking or shaking for 30 min. Mix the reaction solution by gently tapping the tube every 5 minutes. 7. Add 3 μl Stop Solution (Item D) into each reaction tube and immediately dialyze as directed in Steps 1–3 on pages 8-9. Note: Biotinylated samples can be stored at -20°C or -80°C until you are ready to proceed with the assay.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
10
C. Drying the Glass Slide 8. Remove the package containing the Assembled Glass Slide (Item E) from the freezer. Place unopened package on the bench top for approx. 15 min, and allow the Assembled Glass Slide to equilibrate to RT. 9. Open package, and take the Assembled Glass Slide out of the sleeve (Do not disassemble the Glass Slide from the chamber assembly). Place glass slide assembly in laminar flow hood or similar clean environment for 1-2 hours at RT. Note: Protect the slide from dust or other contaminants. D. Blocking and Incubations Note: Glass slide should be completely dry before adding Blocking Buffer to wells. 10. Block sub-arrays by adding 400 μl of Blocking Buffer (Item F) into each well of Assembled Glass Slide and incubating at RT for 30 min. Ensure there are no bubbles on the array surfaces. 11. Immediately prior to sample incubation, spin biotin-labeled samples for 5 min at 10,000 rpm to remove any particulates or precipitates. Dilute samples with Blocking Buffer. Recommended dilution of the biotin-labeled samples with Blocking Buffer is 2-10 fold for cell culture supernatants, 20-fold for serum/plasma and 30 fold cell/tissue lysate. Note: Optimal sample dilution factor will depend on the abundance of target proteins. If the background or antigen-specific antibody signals are too strong, the sample can be diluted further in subsequent experiments. If the signal is too weak, more concentrated samples can be used.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
11
12. Completely remove Blocking Buffer from each well. Add 400 μl of diluted samples into appropriate wells. Remove any bubbles on array surfaces. Incubate arrays with gentle rocking or shaking for 2 hours at RT or overnight at 4°C. Note: Avoid the flow of sample into neighboring wells. 13. Based on number of samples and remaining protocol, calculate the amount of 1X Wash Buffer I and 1X Wash Buffer II needed to complete the experiment. Separately dilute the required amounts of 20X Wash Buffer I Concentrate (Item G) 20-fold and 20X Wash Buffer II Concentrate (Item H) with ddH2O. 14. Decant the samples from each well, and wash 3 times with 800 μl of 1X Wash Buffer I at RT with gentle rocking or shaking for 5 min per wash. 15. Obtain a clean container (e.g., pipette tip box or slide-staining jar), place the Assembled Glass Slide into the container with enough volume of 1X Wash Buffer I to completely cover the entire assembly, and remove any bubbles in wells. Wash 2 times at RT with gentle rocking or shaking for 10 min per wash. 16. Decant the Wash Buffer I from each well, place the Assembled Glass Slide into the container with enough volume of 1X Wash Buffer II to completely cover the entire assembly, and remove any bubbles in wells. Wash 2 times at RT with gentle rocking or shaking for 5 min per wash. 17. Prepare 1X Cy3-Conjugated Streptavidin: a) Briefly spin down tube containing the Cy3-Conjugated Streptavidin (Item I) immediately before use. b) Add 1000 μl of Blocking Buffer into the tube to prepare a concentrated Cy3-Conjugated Streptavidin stock solution. Pipette up and down to mix gently (do not store the stock solution for later use). RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
12
c) To prepare 1X Cy3-Conjugated Streptavidin add 200 μl of the concentrated Cy3-Conjugated Streptavidin stock solution into a tube with 800 μl of Blocking Buffer. Mix gently. 18. Carefully remove Assembled Glass Slide from container. Remove all of Wash Buffer II from the wells. Add 400 μl of 1X Cy3-Conjugated Streptavidin to each sub-array. Cover the incubation chamber with the plastic adhesive strips. Note: Avoid exposure to light in Steps 19–25 by covering the Glass Slide Assembly with aluminum foil or incubate in a dark room. 19. Incubate with 1X Cy3-Conjugated Streptavidin at RT for 2 hours with gentle rocking or shaking. Note: Incubation may be done overnight at 4°C. 20. Decant the solution and disassemble the glass slide from the incubation frame and chamber. Disassemble the device by pushing clips outward from the side, as shown below. Carefully remove the glass slide from the gasket. Note: Be careful not to touch the printed surface of the glass slide, which is on the same side as the barcode. 21. Gently place the glass slide into 30 ml Centrifuge Tube (Item M). Add enough 1X Wash Buffer I to cover the entire glass slide (about 30 ml). Wash with gentle rocking or shaking for 10 min. Remove the wash buffer. Repeat 2 times for a total of 3 washes. 22. Repeat step 20, this time with 1X Wash Buffer II. Repeat one time for a total of two washes for 5 min per wash. 23. Finally, wash the glass slide with 30 ml of ddH2O for 5 min. Remove glass slide and decant water from Centrifuge Tube. 24. Remove buffer droplets from the slide completely by one of the following ways: RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
13
• Put the glass slide into the Slide Washer/Dryer, and dry the glass slide by centrifuge at 1,000 rpm for 3 minutes without cap. • Or, dry the glass slide by a compressed N2 stream. • Or gently apply suction with a pipette to remove buffer droplets. Do not touch the array, only the sides. Note: Make sure the finished glass slide is completely dry before scanning or storage. E. Fluorescence Detection 25. You may proceed immediately to scanning or you may store the slide at -20 °C in the Centrifuge Tube provided or at RT to scan at a later time. Note: Please protect the finished glass slides from temperatures above RT and store them in the dark. Do not expose glass slide to strong light, such as sunlight or a UV lamp. Note: If you need to repeat any of the incubation steps after finishing the experiment, you must first re-assemble the glass slide into the incubation chamber by following the steps as described below. To avoid breaking the printed glass slide, you may first want to practice assembling the device with a blank glass slide. 1. 2. 3. 4.
Apply slide to incubation chamber barcode facing upward (image A). Gently snap one edge of a snap-on side (image B). Gently press other of side against lab bench and push in lengthwise direction (image C). Repeat with the other side (image D)
A
B
C
D
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
14
V. Antibody Array Maps and Target Lists A. RayBio® Human Antibody Array L-507 Map 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
P-1a
P-1a
P-2a
P-2a
P-3a
P-3a
Neg
Neg
5
5
6
6
7
7
8
8
9
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
25
25
26
26
27
27
28
28
29
29
30
30
31
31
32
32
33
33
34
34
35
35
36
36
37
37
38
38
39
39
40
40
41
41
42
42
43
43
44
44
45
45
46
46
47
47
48
48
49
49
50
50
51
51
52
52
53
53
54
54
55
55
56
56
57
57
58
58
59
59
60
60
61
61
62
62
63
63
64
64
65
65
66
66
67
67
68
68
69
69
70
70
71
71
72
72
73
73
74
74
75
75
76
76
77
77
78
78
79
79
80
80
81
81
82
82
83
83
84
84
85
85
86
86
87
87
88
88
89
89
90
90
91
91
92
92
93
93
94
94
95
95
96
96
97
97
98
98
99
99
100
100
101
101
102
102
103
103
104
104
105
105
106
106
107
107
108
108
109
109
110
110
111
111
112
112
113
113
114
114
115
115
116
116
117
117
118
118
119
119
120
120
121
121
122
122
123
123
124
124
125
125
126
126
127
127
128
128
129
129
130
130
131
131
132
132
133
133
134
134
135
135
136
136
137
137
138
138
139
139
140
140
141
141
142
142
143
143
144
144
145
145
146
146
147
147
148
148
149
149
150
150
151
151
152
152
153
153
154
154
155
155
156
156
157
157
158
158
159
159
160
160
161
161
162
162
163
163
164
164
165
165
166
166
167
167
168
168
169
169
170
170
171
171
172
172
173
173
174
174
175
175
176
176
177
177
178
178
179
179
180
180
181
181
182
182
183
183
184
184
185
185
186
186
187
187
188
188
189
189
190
190
191
191
192
192
193
193
194
194
195
195
196
196
197
197
198
198
199
199
200
200
201
201
202
202
203
203
204
204
205
205
206
206
207
207
208
208
209
209
210
210
211
211
212
212
213
213
214
214
215
215
216
216
217
217
218
218
219
219
220
220
221
221
222
222
223
223
224
224
225
225
226
226
227
227
228
228
229
229
230
230
231
231
232
232
233
233
234
234
235
235
236
236
237
237
238
238
239
239
240
240
241
241
242
242
243
243
244
244
245
245
246
246
247
247
248
248
249
249
250
250
251
251
252
252
253
253
254
254
255
255
256
256
257
257
258
258
259
259
260
260
261
261
262
262
263
263
264
264
265
265
266
266
267
267
268
268
269
269
270
270
271
271
272
272
273
273
274
274
275
275
276
276
277
277
278
278
279
279
280
280
281
281
282
282
283
283
284
284
285
285
P-1b
P-1b
P-2b
P-2b
P-3b
P-3b
Neg
Neg
290
290
291
291
292
292
293
293
294
294
295
295
296
296
297
297
298
298
299
299
300
300
301
301
302
302
303
303
304
304
305
305
306
306
307
307
308
308
309
309
310
310
311
311
312
312
313
313
314
314
315
315
316
316
317
317
318
318
319
319
320
320
321
321
322
322
323
323
324
324
325
325
326
326
327
327
328
328
329
329
330
330
331
331
332
332
333
333
334
334
335
335
336
336
337
337
338
338
339
339
340
340
341
341
342
342
343
343
344
344
345
345
346
346
347
347
348
348
349
349
350
350
351
351
352
352
353
353
354
354
355
355
356
356
357
357
358
358
359
359
360
360
361
361
362
362
363
363
364
364
365
365
366
366
367
367
368
368
369
369
370
370
371
371
372
372
373
373
374
374
375
375
376
376
377
377
378
378
379
379
380
380
381
381
382
382
383
383
384
384
385
385
386
386
387
387
388
388
389
389
390
390
391
391
392
392
393
393
394
394
395
395
396
396
397
397
398
398
399
399
400
400
401
401
402
402
403
403
404
404
405
405
406
406
407
407
408
408
409
409
410
410
411
411
412
412
413
413
414
414
415
415
416
416
417
417
418
418
419
419
420
420
421
421
422
422
423
423
424
424
425
425
426
426
427
427
428
428
429
429
430
430
431
431
432
432
433
433
434
434
435
435
436
436
437
437
438
438
439
439
440
440
441
441
442
442
443
443
44
444
445
445
446
446
447
447
448
448
449
449
450
450
451
451
452
452
453
453
454
454
455
455
456
456
457
457
458
458
459
459
460
460
461
461
462
462
463
463
464
464
465
465
466
466
467
467
468
468
469
469
470
470
471
471
472
472
473
473
474
474
475
475
476
476
477
477
478
478
479
479
480
480
481
481
482
482
483
483
484
484
485
485
486
486
487
487
488
488
489
489
490
490
491
491
492
492
493
493
494
494
495
495
496
496
497
497
498
498
499
499
500
500
501
501
502
502
503
503
504
504
505
505
506
506
507
507
508
508
509
509
510
510
511
511
512
512
513
513
514
514
515
515
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
P-3c
P-3c
P-2c
P-2c
P-1c
P-1c
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
15
B. RayBio Human Antibody Array L-507 Target List Number
Name
Number
Name
Number
Name
Number
Name
Number
Name
1
Positive 1a
61
CCR7
121
Eotaxin-2 / MPIF-2
181
GFR alpha-2
241
IL-1 R6 / IL-1 Rrp2
2
Positive 2a
62
CCR8
122
Eotaxin-3 / CCL26
182
GFR alpha-3
242
IL-1 R8
3
Positive 3a
63
CCR9
123
Epiregulin
183
GFR alpha-4
243
IL-1 R9
4
neg
64
CD14
124
ErbB2
184
GITR / TNFRF18
244
IL-1 ra
5
6Ckine
65
CD27 / TNFRSF7
125
ErbB3
185
GITR Ligand / TNFSF18
245
IL-1 sRI
6
Activin A
66
CD30 / TNFRSF8
126
ErbB4
186
Glucagon
246
IL-1 sRII
7
Activin B
67
CD30 Ligand / TNFSF8
127
Erythropoietin
187
Glut1
247
IL-2
8
Activin C
68
CD40 / TNFRSF5
128
E-Selectin
188
Glut2
248
IL-2 R alpha
9
Activin RIA / ALK-2
69
CD40 Ligand / TNFSF5 /CD154
129
FADD
189
Glut3
249
IL-2 R beta /CD122
10
Activin RIB / ALK-4
70
CD 163
130
FAM3B
190
Glut5
250
IL-2 R gamma
11
Activin RII A/B
71
Cerberus 1
131
Fas / TNFRSF6
191
Glypican 3
251
IL-3
12
Activin RIIA
72
Chem R23
132
Fas Ligand
192
Glypican 5
252
IL-3 R alpha
13
Adiponectin / Acrp30
73
Chordin-Like 1
133
FGF Basic
193
GM-CSF
253
IL-4
14
AgRP
74
Chordin-Like 2
134
FGF-BP
194
GM-CSF R alpha
254
IL-4 R
15
ALCAM
75
CLC
135
FGF R3
195
Granzyme A
255
IL-5
16
Angiogenin
76
CNTF
136
FGF R4
196
GREMLIN
256
IL-5 R alpha
17
Angiopoietin-1
77
CNTF R alpha
137
FGF R5
197
GRO
257
IL-6
18
Angiopoietin-2
78
Coagulation Factor III / Tissue Factor
138
FGF-4
198
GRO-a
258
IL-6 R
19
Angiopoietin-4
79
CRIM 1
139
FGF-5
199
Growth Hormone (GH)
259
IL-7
20
Angiopoietin-like 1
80
Cripto-1
140
FGF-6
200
Growth Hormone R (GHR)
260
IL-7 R alpha
21
Angiopoietin-like 2
81
CRTH-2
141
FGF-7 / KGF
201
HB-EGF
261
IL-8
22
Angiopoietin-like Factor
82
Cryptic
142
FGF-8
202
HCC-4 / CCL16
262
IL-9
23
Angiostatin
83
Csk
143
FGF-9
203
HCR / CRAM-A/B
263
IL-10
24
APJ
84
CTACK / CCL27
144
FGF-10 / KGF-2
204
Hepassocin
264
IL-10 R alpha IL-10 R beta
25
APRIL
85
CTGF / CCN2
145
FGF-11
205
GLO-1
265
26
AR (Amphiregulin)
86
CTLA-4 /CD152
146
FGF-12
206
HGF
266
IL-11
27
Artemin
87
CV-2 / Crossveinless-2
147
FGF-13 1B
207
HGFR
267
IL-12 p40
28
Axl
88
CXCL14 / BRAK
148
FGF-16
208
HRG-alpha
268
IL-12 p70
29
B7-1 /CD80
89
CXCL16
149
FGF-17
209
HRG-beta 1
269
IL-12 R beta 1
30
BAFF R / TNFRSF13C
90
CXCR1 / IL-8 RA
150
FGF-18
210
HVEM / TNFRSF14
270
IL-12 R beta 2
31
BCMA / TNFRSF17
91
CXCR2 / IL-8 RB
151
FGF-19
211
I-309
271
IL-13
32
BD-1
92
CXCR3
152
FGF-20
212
ICAM-1
272
IL-13 R alpha 1
33
BDNF
93
CXCR4 (fusin)
153
FGF-21
213
ICAM-2
273
IL-13 R alpha 2
34
beta-Catenin
94
CXCR5 /BLR-1
154
FGF-23
214
ICAM-3 (CD50)
274
IL-15
35
BAX
95
CXCR6
155
FLRG
215
ICAM-5
275
IL-15 R alpha
36
beta-NGF
96
D6
156
Flt-3 Ligand
216
IFN-alpha / beta R1
276
IL-16
37
BIK
97
DAN
157
Follistatin
217
IFN-alpha / beta R2
277
IL-17
38
BLC / BCA-1 / CXCL13
98
DANCE
158
Follistatin-like 1
218
IFN-beta
278
IL-17B
39
BMP-2
99
DcR3 / TNFRSF6B
159
Fractalkine
219
IFN-gamma
279
IL-17B R
40
BMP-3
100
Decorin
160
Frizzled-1
220
IFN-gamma R1
280
IL-17C
41
BMP-3b / GDF-10
101
Dkk-1
161
Frizzled-3
221
IGFBP-1
281
IL-17D
42
BMP-4
102
Dkk-3
162
Frizzled-4
222
IGFBP-2
282
IL-17E
43
BMP-5
103
Dkk-4
163
Frizzled-5
223
IGFBP-3
283
IL-17F
44
BMP-6
104
DR3 / TNFRSF25
164
Frizzled-6
224
IGFBP-4
284
IL-17R
45
BMP-7
105
DR6 / TNFRSF21
165
Frizzled-7
225
IGFBP-6
285
IL-17RC
46
BMP-8
106
Dtk
166
Galectin-3
226
IGFBP-rp1 / IGFBP-7
286
Positive 1b
47
BMP-15
107
EDA-A2
167
GASP-1 / WFIKKNRP
227
IGF-I
287
Positive 2b
48
BMPR-IA / ALK-3
108
EDAR
168
GASP-2 / WFIKKN
228
IGF-I SR
288
Positive 3b
49
BMPR-IB / ALK-6
109
EDG-1
169
GCP-2 / CXCL6
229
IGF-II
289
neg
50
BMPR-II
110
EGF
170
GCSF
230
IGF-II R
290
IL-17RD
51
BTC
111
EGF R / ErbB1
171
G-CSF R / CD 114
231
IL-1 alpha
291
IL-18 BPa
52
Cardiotrophin-1 / CT-1
112
EG-VEGF / PK1
172
GDF1
232
IL-1 beta
292
IL-18 R alpha /IL-1 R5
53
CCL14 / HCC-1 / HCC-3
113
EMAP-II
173
GDF3
233
IL-1 F5 / FIL1delta
293
IL-18 R beta /AcPL
54
CCL28 / VIC
114
ENA-78
174
GDF5
234
IL-1 F6 / FIL1 epsilon
294
IL-19
55
CCR1
115
Endocan
175
GDF8
235
IL-1 F7 / FIL1 zeta
295
IL-20
56
CCR2
116
Endoglin / CD105
176
GDF9
236
IL-1 F8 / FIL1 eta
296
IL-20 R alpha
57
CCR3
117
Endostatin
177
GDF11
237
IL-1 F9 / IL-1 H1
297
IL-20 R beta
58
CCR4
118
Endothelin
178
GDF-15
238
IL-1 F10 / IL-1HY2
298
IL-21
59
CCR5
119
EN-RAGE
179
GDNF
239
IL-1 R3 / IL-1 R AcP
299
IL-21 R
60
CCR6
120
Eotaxin / CCL11
180
GFR alpha-1
240
IL-1 R4 / ST2
300
IL-22
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
16
RayBio Human Antibody Array L-507 Target List… continued Number
Name
Number
Name
Number
Name
Number
Name
301
IL-22 BP
361
MMP-2
421
RANK / TNFRSF11A
481
TMEFF1 / Tomoregulin-1
302
IL-22 R
362
MMP-3
422
RANTES
482
TMEFF2
303
IL-23
363
MMP-7
423
RELM beta
483
TNF-alpha
304
IL-23 R
364
MMP-8
424
RELT / TNFRSF19L
484
TNF-beta
305
IL-24
365
MMP-9
425
ROBO4
485
TNF RI / TNFRSF1A
306
IL-26
366
MMP-10
426
S100 A8/A9
486
TNF RII / TNFRSF1B
307
IL-27
367
MMP-11 /Stromelysin-3
427
S100A10
487
TRADD
308
IL-28A
368
MMP-12
428
SAA
488
TRAIL / TNFSF10
309
IL-29
369
MMP-13
429
SCF
489
TRAIL R1 / DR4 / TNFRSF10A
310
IL-31
370
MMP-14
430
SCF R /CD117
490
TRAIL R2 / DR5 / TNFRSF10B
311
IL-31 RA
371
MMP-15
431
SDF-1 / CXCL12
491
TRAIL R3 / TNFRSF10C
312
BACE-1
372
MMP-16 / MT3-MMP
432
sFRP-1
492
TRAIL R4 / TNFRSF10D
313
FACX
373
MMP-19
433
sFRP-3
493
TRANCE
314
Insulin
374
MMP-20
434
sFRP-4
494
TREM-1
315
Insulin R
375
MMP-24 / MT5-MMP
435
sgp130
495
TROY / TNFRSF19
316
Insulysin / IDE
376
MMP-25 / MT6-MMP
436
SIGIRR
496
TSG-6
317
IP-10
377
MSP alpha Chain
437
Siglec-5/CD170
497
TSLP R
318
I-TAC / CXCL11
378
Musk
438
Siglec-9
498
TWEAK / TNFSF12
319
Kininostatin / kininogen
379
NAP-2
439
SLPI
499
TWEAK R / TNFRSF12
320
Kremen-1
380
NCAM-1 / CD56
440
Smad 1
500
Ubiquitin+1
321
Kremen-2
381
Neuritin
441
Smad 4
501
uPA
322
Latent TGF-beta bp1
382
NeuroD1
442
Smad 5
502
uPAR
323
LBP
383
Neuropilin-2
443
Smad 7
503
Vasorin
324
Lck
384
Neurturin
444
Smad 8
504
VCAM-1 (CD106) VE-Cadherin
325
LECT2
385
NGF R
445
Prdx6
505
326
Lefty - A
386
Nidgen-1
446
Soggy-1
506
VEGF
327
Leptin (OB)
387
NOV / CCN3
447
Sonic Hedgehog (Shh N-terminal)
507
VEGF R2 (KDR)
328
Leptin R
388
NrCAM
448
SPARC
508
VEGF R3
329
LFA-1 alpha
389
NRG1 Isoform GGF2
449
Spinesin
509
VEGF-B
330
LIF
390
NRG2
450
TACI / TNFRSF13B
510
VEGF-C
331
LIF R alpha
391
NRG3
451
Tarc
511
VEGF-D
332
LIGHT / TNFSF14
392
NT-3
452
TCCR / WSX-1
512
VEGI / TNFSF15
333
Lipocalin-1
393
NT-4
453
TECK / CCL25
513
WIF-1
334
Lipocalin-2
394
Orexin A
454
TFPI
514
WISP-1 / CCN4
335
LRP-1
395
Orexin B
455
TGF-alpha
515
XEDAR
336
LRP-6
396
OSM
456
TGF-beta 1
516
Neg
337
L-Selectin (CD62L)
397
Osteoactivin / GPNMB
457
TGF-beta 2
517
Neg
338
Lymphotactin / XCL1
398
Osteocrin
458
TGF-beta 3
518
Neg
339
Lymphotoxin beta / TNFSF3
399
Osteoprotegerin / TNFRSF11B
459
TGF-beta 5
519
Neg
340
Lymphotoxin beta R / TNFRSF3
400
OX40 Ligand / TNFSF4
460
TGF-beta RI / ALK-5
520
Neg
341
MAC-1
401
PARC / CCL18
461
TGF-beta RII
521
Neg
342
MCP-1
402
PD-ECGF
462
Grb2
522
Neg
343
MCP-2
403
PDGF R alpha
463
TGF-beta RIII
523
P-3c
344
MCP-3
404
PDGF R beta
464
Thrombopoietin (TPO)
524
P-2c
345
MCP-4 / CCL13
405
PDGF-AA
465
TPX
525
P-1c
346
M-CSF
406
PDGF-AB
466
Thrombospondin-1
347
M-CSF R
407
PDGF-BB
467
Thrombospondin-2
348
MDC
408
PDGF-C
468
Thrombospondin-4
349
MFG-E8
409
PDGF-D
469
Thymopoietin
350
MFRP
410
PECAM-1 /CD31
470
Tie-1
351
MICA
411
Pentraxin3 / TSG-14
471
Tie-2
352
MIF
412
Persephin
472
TIMP-1
353
MIG
413
PF4 / CXCL4
473
TIMP-2
354
MIP-1a
414
PlGF
474
TIMP-3
355
MIP-1b
415
PLUNC
475
TIMP-4
356
MIP-1d
416
Pref-1
476
TL1A / TNFSF15
357
MIP 2
417
Progranulin
477
TLR1
358
MIP-3 alpha
418
Prolactin
478
TLR2
359
MIP-3 beta
419
P-selectin
479
TLR3
360
MMP-1
420
RAGE
480
TLR4
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
17
C. RayBio Human Antibody Array L-493 Map 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
P-1a
P-1a
P-2a
P-2a
P-3a
P-3a
Neg
Neg
5
5
6
6
7
7
8
8
9
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
25
25
26
26
27
27
28
28
29
29
30
30
31
31
32
32
33
33
34
34
35
35
36
36
37
37
38
38
39
39
40
40
41
41
42
42
43
43
44
44
45
45
46
46
47
47
48
48
49
49
50
50
51
51
52
52
53
53
54
54
55
55
56
56
57
57
58
58
59
59
60
60
61
61
62
62
63
63
64
64
65
65
66
66
67
67
68
68
69
69
70
70
71
71
72
72
73
73
74
74
75
75
76
76
77
77
78
78
79
79
80
80
81
81
82
82
83
83
84
84
85
85
86
86
87
87
88
88
89
89
90
90
91
91
92
92
93
93
94
94
95
95
96
96
97
97
98
98
99
99
100
100
101
101
102
102
103
103
104
104
105
105
106
106
107
107
108
108
109
109
110
110
111
111
112
112
113
113
114
114
115
115
116
116
117
117
118
118
119
119
120
120
121
121
122
122
123
123
124
124
125
125
126
126
127
127
128
128
129
129
130
130
131
131
132
132
133
133
134
134
135
135
136
136
137
137
138
138
139
139
140
140
141
141
142
142
143
143
144
144
145
145
146
146
147
147
148
148
149
149
150
150
151
151
152
152
153
153
154
154
155
155
156
156
157
157
158
158
159
159
160
160
161
161
162
162
163
163
164
164
165
165
166
166
167
167
168
168
169
169
170
170
171
171
172
172
173
173
174
174
175
175
176
176
177
177
178
178
179
179
180
180
181
181
182
182
183
183
184
184
185
185
186
186
187
187
188
188
189
189
190
190
191
191
192
192
193
193
194
194
195
195
196
196
197
197
198
198
199
199
200
200
201
201
202
202
203
203
204
204
205
205
206
206
207
207
208
208
209
209
210
210
211
211
212
212
213
213
214
214
215
215
216
216
217
217
218
218
219
219
220
220
221
221
222
222
223
223
224
224
225
225
226
226
227
227
228
228
229
229
230
230
231
231
232
232
233
233
234
234
235
235
236
236
237
237
238
238
239
239
240
240
241
241
242
242
243
243
244
244
245
245
246
246
247
247
248
248
249
249
250
250
251
251
252
252
253
253
254
254
255
255
256
256
257
257
258
258
259
259
260
260
261
261
262
262
263
263
264
264
265
265
266
266
267
267
268
268
269
269
270
270
271
271
272
272
273
273
274
274
275
275
276
276
277
277
278
278
279
279
280
280
281
281
282
282
283
283
284
284
285
285
P-1b
P-1b
P-2b
P-2b
P-3b
P-3b
Neg
Neg
290
290
291
291
292
292
293
293
294
294
295
295
296
296
297
297
298
298
299
299
300
300
301
301
302
302
303
303
304
304
305
305
306
306
307
307
308
308
309
309
310
310
311
311
312
312
313
313
314
314
315
315
316
316
317
317
318
318
319
319
320
320
321
321
322
322
323
323
324
324
325
325
326
326
327
327
328
328
329
329
330
330
331
331
332
332
333
333
334
334
335
335
336
336
337
337
338
338
339
339
340
340
341
341
342
342
343
343
344
344
345
345
346
346
347
347
348
348
349
349
350
350
351
351
352
352
353
353
354
354
355
355
356
356
357
357
358
358
359
359
360
360
361
361
362
362
363
363
364
364
365
365
366
366
367
367
368
368
369
369
370
370
371
371
372
372
373
373
374
374
375
375
376
376
377
377
378
378
379
379
380
380
381
381
382
382
383
383
384
384
385
385
386
386
387
387
388
388
389
389
390
390
391
391
392
392
393
393
394
394
395
395
396
396
397
397
398
398
399
399
400
400
401
401
402
402
403
403
404
404
405
405
406
406
407
407
408
408
409
409
410
410
411
411
412
412
413
413
414
414
415
415
416
416
417
417
418
418
419
419
420
420
421
421
422
422
423
423
424
424
425
425
426
426
427
427
428
428
429
429
430
430
431
431
432
432
433
433
434
434
435
435
436
436
437
437
438
438
439
439
440
440
441
441
442
442
443
443
44
444
445
445
446
446
447
447
448
448
449
449
450
450
451
451
452
452
453
453
454
454
455
455
456
456
457
457
458
458
459
459
460
460
461
461
462
462
463
463
464
464
465
465
466
466
467
467
468
468
469
469
470
470
471
471
472
472
473
473
474
474
475
475
476
476
477
477
478
478
479
479
480
480
481
481
482
482
483
483
484
484
485
485
486
486
487
487
488
488
489
489
490
490
491
491
492
492
493
493
494
494
495
495
496
496
497
497
498
498
499
499
500
500
501
501
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
Neg
P-3c
P-3c
P-2c
P-2c
P-1c
P-1c
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
18
D. RayBio Human Antibody Array L-493 Target List Number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Name Positive-1a Positive-2a Positive-3a Blank 11b-HSD1 2B4 4-1BB ABL1 ACE ACE-2 ACK1 ACPP ACTH ADAM-9 Neurokinin-A ADAMTS-1 ADAMTS-L2 ADAMTS-4 ADAMTS-5 ADAMTS-10 ADAMTS-13 ADAMTS-15 ADAMTS-17 ADAMTS-18 ADAMTS-19 Adipsin Afamin AFP ALBUMIN IL-36RN Aldolase A Aldolase B Aldolase C ALK Alpha Lactalbumin Alpha 1 AG A1BG A1M A2M TPM1 ALPP pro-MMP13 AMICA AMPKa1 Amylin ANGPTL3 ANGPTL4 Annexin A7 APC APCS Apelin Apex1 APN ApoA1 ApoA2 ApoA4 ApoB ApoC2 ApoB100 ApoE
Number 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Name ApoE3 ApoD ApoM ApoH APP ASPH Attractin B3GNT1 BAF57 BAFF BAI-1 BCAM Beta 2M Beta Defensin 4 Beta IG-H3 Biglycan BLAME BMP-9 BMX BNIP2 Btk ApoC1 CA 9 CA 15-3 CA 19-9 CA 125 Cadherin-13 Calbindin Calbindin D Calcitonin Calreticulin Calsyntenin-1 CPN2 CART Caspase-3 Caspase-8 Cathepsin B Cathepsin D Cathepsin L Cathepsin S CBP CCK CD23 CD24 CD36 CD38 CD44 CD45 CD46 CD47 CD55 CD59 CD71 CD74 CD90 CD97 CD 79 alpha CD200 CEA CEACAM-1
Number Name 121 Ceruloplasmin 122 CFHR2 123 Chemerin 124 CHI3L1 125 Chromogranin A 126 Chymase 127 cIAP-2 128 Ck beta 8-1 129 CK-MB 130 Claudin-3 131 Claudin-4 132 CLEC3B 133 Clusterin 134 CNDP1 135 Factor XIII A 136 Factor XIII B 137 COCO 138 C2 139 C3a 140 C5/C5a 141 C7 142 C8B 143 C9 144 Complement factor H 145 Contactin-1 146 Contactin-2 147 Corticosteroid-binding globulin 148 COX-2 149 C-peptide 150 Creatinine 151 CRP 152 CRTAM 153 CSH1 154 gamma-Thrombin 155 CutA 156 cTnT 157 Cyclin D1 158 Cystatin A 159 Cystatin B 160 Cystatin C 161 Cytochrome C 162 Cytokeratin 8 163 Cytokeratin 18 164 Cytokeratin 19 165 DBI 166 DCBLD2 167 D-Dimer 168 DEFA1/3 169 Defensin 170 Desmin 171 DLL1 172 DLL4 173 DMP-1 174 DPPIV 175 BNP 176 E-Cadherin 177 Endorphin Beta 178 Endothelin Receptor A 179 Enolase 2 180 ENPP2
Number 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
Name EpCAM EphA1 EphA2 EphA3 EphA4 EphA5 EphA6 EphA7 EphA8 EphB1 EphB2 EphB3 EphB4 EphB6 ERRa Erythropoietin R ESAM EV15L EXTL2 FABP1 FABP2 FABP4 FAK FAP Fc RIIB/C Fen 1 FER Ferritin Fetuin A Fetuin B FGFR1 FGFR1 alpha FGFR2 Fibrinogen Fibrinopeptide A Fibronectin Ficolin-3 FIH FOLR1 FOXN3 FoxO1 FoxP3 FRK FSH Furin Fyn GADD45A Galectin-1 Galectin-3BP Galectin-7 Gas1 Gastrin GATA-3 GATA-4 Gelsolin Ghrelin GLP-1 GPI GPBB GMNN
Number 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300
Name GPR-39 GPX1 GPX3 Pancreastatin GRP GRP75 GRP78 GSR GST HADHA HAI-1 HAI-2 hCG alpha hCGb Hck HE4 Hemopexin Hepcidin HSP32 HOXA10 Haptoglobin HSP10 HSP20 HSP27 HSP40 HSP60 HSP70 HSP90 HSPA8 HTRA2 IBSP IGF2BP1 IGFBP-5 IL-23p19 IL-33 IL-34 INSRR Integrin alpha V CD61 Itk ITM2B Kallikrein 2 ApoC3 Kallikrein 5 Kallikrein 6 Positive-1b Positive-2b Positive-3b neg Kallikrein 7 Kallikrein 8 Kallikrein 10 Kallikrein 11 Kallikrein 14 KCC3 KCTD10 KIF3B KLF4 LAG-3 pro-Glucagon
19
RayBio® Human Antibody Array L-493 Target List ...continued Number 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360
Name Layilin LDL R Legumain LH LIMPII LIN41 Livin LOX-1 LPS LRG1 LTF LTK Lumican Lyn LYRIC LYVE-1 LZTS1 Mammaglobin A Marapsin MATK MBL MBL-2 Mer Mesothelin MICB Midkine MINA FABP3 MSHa MTUS1 Myoglobin NAIP Nanog NELL2 NEP Galanin Nesfatin Nestin NET1 Netrin G2 Netrin-4 Neuropeptide Y NF1 NM23-H1/H2 Presenilin 2 Notch-1 NPTX1 NPTXR Progesterone Ntn1 OCT3/4 Omentin Osteocalcin Osteopontin OX40 p21 p27 p53 PAI-1 PAK7
Number 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420
Name Pappalysin-1 Pancreatic Polypeptide Presenilin 1 PARK7 Visfatin P-Cadherin PCAF PD-1 PTH Troponin C PDX-1 PEDF PEPSINOGEN I PEPSINOGEN II Vasopressin PGRP-S PI 16 PI 3Kinase p85 beta PIM2 PKM2 Plasminogen Podocalyxin POMC PON1 PON2 PPARg2 PPP2R5C NR3C3 INSL3 Pro-BDNF Procalcitonin Pro-Cathepsin B Thrombin Prohibitin ProSAAS Prostasin PSP Pro-MMP-7 Pro-MMP-9 Protein p65 PSA-Free PSA-total PTHLP PTN PTPRD PYK2 PYY Ras RBP4 RECK RELM alpha Resistin RET RIP1 ROCK1 ROCK2 ROR1 ROR2 ROS RYK
Number 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480
Name S100A4 S100A6 S100A8 S-100b SART1 SART3 SCG3 Selenoprotein P SEMA3A Serotonin Serpin A1 Serpin A12 Serpin A3 Serpin A4 Serpin A5 Serpin A8 Serpin A9 Serpin B5 Serpin D1 Serpin I1 SERPING1 SERTAD2 SHBG SMAC SNCG SSTR5 Somatotropin SOST SOX17 SOX2 SPARCL1 SPINK1 SRMS SSEA-1 SSEA-4 SSTR2 Survivin SYK Syndecan-1 Syndecan-3 TACE TAF4 Tyk2 Tec TFF3 Thrombomodulin Thymidine Kinase-1 Thyroglobulin TIM-1 TNK1 TOPORS TPA TRA-1-60 TRA-1-81 Transferrin Trappin-2 TRKB TROPONIN I TYRO10 TRPC1
Number 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
Name TRPC6 TRPM7 Trypsin 1 TSH TSLP TXK Uromodulin TFF1 VDUP-1 VEGF R1 VGF VIP Receptor 2 Vitamin D Receptor Vitamin D-BP Vitamin K-dependent protein S Vitronectin VWF Wilms Tumor 1 XIAP ZAG ZAP70 Neg Neg Neg Neg Neg Neg Positive-3c Positive-2c Positive-1c
20
VI. Interpretation of Results: A. Explanation of Controls Spots 1)
Positive Control spots (POS1, POS2, POS3) are standardized amounts of biotinylated IgGs printed directly onto the array. All other variables being equal, the Positive Control intensities will be the same for each sub-array. This allows for normalization based upon the relative fluorescence signal responses to a known control, much as “housekeeping” genes or proteins are used to normalize results in PCR or Western blots, respectively.
2)
Negative Control (NEG) spots contain a protein-containing buffer (used to dilute antibodies printed on the array). Their signal intensities represent non-specific binding of the Cy3-Conjugated Streptavidin. Negative control signal intensities are usually very close to background signals in each sub-array.
B. Typical Results The following figure shows the RayBio® L-Series Human Antibody Array 1000 probed with serum sample. The images were captured using a Axon GenePix laser scanner. The strong signals in row 20 and the upper left and lower right corners of each array are Positive Controls, which can be used to identify the orientation and help normalize the results between arrays.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
21
RayBio® L-Series Human Antibody Array 507
Sample-1
Sample-2
RayBio® L-Series Human Antibody Array L-493
Sample-1
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
Sample-2
22
If scanned using optimal settings, 3 distinct signal intensities will be seen: POS1>POS2>POS3. If all of these signals are of similar intensity, try increasing or decreasing laser power and/or signal gain settings. Note: In the absence of an external standard curve for each protein detected, there is no means of assessing absolute or relative concentrations of different proteins in the same sample using immunoassays. If you wish to obtain quantitative data (ie, concentrations of the various analytes in your samples), try using our Quantibody® Arrays as a targeted follow up experiment. C. Background Subtraction Once you have obtained fluorescence intensity data, you should subtract the background and normalize to the Positive Control signals before proceeding to analysis. Most laser fluorescence scanners’ software have an option to automatically measure the local background around each spot. For best results, we recommend comparing signal intensities representing the MEDIAN background signals minus local background. If your resulting fluorescence signal intensity reports do not include these values (e.g., a column labeled as “MED532-B532”), you may need to subtract the background manually or change the default settings on your scanner’s data report menu. D. Normalization of Array Data To normalize signal intensity data, one sub-array is defined as "reference" to which the other arrays are normalized. This choice is arbitrary. For example, in our Analysis Tool Software (described below), the array represented by data entered in the left-most column each worksheet is the default “reference array.”
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
23
You can calculate the normalized values as follows: X(Ny) = X(y) * P1/P(y) Where: P1 = mean signal intensity of POS spots on reference array P(y) = mean signal intensity of POS spots on Array "y" X(y) = mean signal intensity for spot "X" on Array "y" X(Ny) = normalized signal intensity for spot "X" on Array "y" The RayBio® Analysis Tool software is available for use with data obtained using RayBio® Biotin Label-based Antibody Arrays. You can copy and paste your signal intensity data (with and without background) into the Analysis Tool, and it will automatically normalize signal intensities to the Positive Controls. To order the Analysis Tool, please contact us at +1-770-729-2992 or
[email protected] for more information. E. Threshold of Significant Difference After subtracting background signals and normalization to Positive Controls, comparison of signal intensities between and among array images can be used to determine relative differences in expression levels of each protein between samples or groups. Any ≥1.5-fold increase or ≤0.65-fold decrease in signal intensity for a single analyte between samples or groups may be considered a measurable and significant difference in expression, provided that both sets of signals are well above background (Mean background + 2 standard deviations, accuracy ≈ 95%).
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
24
VII. Troubleshooting Guide Problem
Cause Inadequate detection Inadequate reagent volumes or improper dilution Short incubation time
Weak Signal Too low protein concentration in sample Improper storage of kit Bubble formed during incubation Uneven signal
Arrays are not completed covered by reagent Reagent evaporation Cross-contamination from neighboring wells Comet tail formation
General
Inadequate detection
Overexposure Dark spots High background
Insufficient wash Dust Slide is allowed to dry out
Recommendation Increase laser power and PMT parameters Check pipettes and ensure correct preparation Ensure sufficient incubation time and change sample incubation step to overnight Dilute starting sample less or concentrate sample Store kit as suggested temperature. Don’t freeze/thaw the slide. Handle and pipette solutions more gently; De-gas solutions prior to use Prepare more reagent and completely cover arrays with solution Cover the incubation chamber with adhesive film during incubation Avoid overflowing wash buffer between wells Air dry the slide for at least 1 hour before usage Increase laser power so the highest standard concentration for each cytokine receives the highest possible reading yet remains unsaturated Lower the laser power Completely remove wash buffer in each wash step Increase wash time and use more wash buffer Minimize dust in work environment before starting experiment Take additional precautions to prevent slides from dying out during experiment
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
25
VIII. Selected References Christina Scheel et all., Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast. Cell. 2011;145, 926–940 Lin Y, Huang R, Chen L, et al., Profiling of cytokine expression by biotinlabeled-based protein arrays. Proteomics. 2003, 3: 1750–1757. Huang R, Jiang W, Yang J, et al., A Biotin Label-based Antibody Array for High-content Profiling of Protein Expression. Cancer Genomics Proteomics. 2010; 7(3):129–141. Liu T, Xue R, Dong L, et al., Rapid determination of serological cytokine biomarkers for hepatitis B–virus-related hepatocellulare carcinoma using antibody arrays. Acta Biochim Biophys Sin. 2011; 43(1):45–51. Cui J, Chen Y, Chou W-C, et al., An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucl Acids Res. 2011; 39(4):1197–1207. Jun Zhong et all., Temporal Profiling of the Secretome during Adipogenesis in Humans. Journal of Proteome Research. 2010, 9, 5228–5238 Chowdury UR, Madden BJ, Charlesworth MC, Fautsch MP., Proteomic Analysis of Human Aqueous Humor. Invest Ophthalmol Visual Sci. 2010; 51(10):4921–4931. Wei Y, Cui C, Lainscak M, et al., Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationshp between MMP-10 andLV remodeling. J Cell Mol Med. 2011; 15(4):773–782. Kuranda K, Berthon C, Lepêtre F, et al., Expression of CD34 in hematopoietic cancer cell lines reflects tightly regulated stem/progenitorlike state. J Cell Biochem. 2011; 112(5):1277–1285. Toh HC, Wang W-W, Chia WK, et al., Clinical Benefit of Allogenic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGEPositive Colorectal Cancer Patients. Clin Chem Res. 2009; 15:7726–7736. RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
26
Zhen Hou, Cytokine array analysis of peritoneal fluid between women with endometriosis of different stages and those without endometriosi. Biomarkers. 2009;14(8): 604-618. Yao Liang Tang, et al., Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4. Circ Res. 2009;109:197723
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
27
RayBio® L-series Antibody Arrays are patent-pending technology developed by RayBiotech. This product is intended for research only and is not to be used for clinical diagnosis. Our produces may not be resold, modified for resale, or used to manufacture commercial products without written approval by RayBiotech, Inc. Under no circumstances shall RayBiotech be liable for any damages arising out of the use of the materials. Products are guaranteed for six months from the date of shipment when handled and stored properly. In the event of any defect in quality or merchantability, RayBiotech’s liability to buyer for any claim relating to products shall be limited to replacement or refund of the purchase price.
RayBio® is a registered trademark of RayBiotech, Inc. HyLite Plus™ is a trademark of Anaspec, Inc. GenePix® is a registered trademark of Molecular Devices, Inc.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
28
This product is for research use only.
©2011 RayBiotech, Inc.
RayBio® L-Series Human Antibody Array L-507 or L-493 Protocol
29